Alector Inc.

ALEC | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.93

+$0.02 (+1.05%)

At close: Sep 21, 2026, 4:00 PM ET

$1.90

-$0.03 (-1.55%)

Pre-market: Sep 22, 2026, 6:20 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.05%

(1D)

Rating

Updated: Aug 25, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $214.28M

1D Range

1.86 1.95

52W Range

1.09 3.40

Valuation (TTM)

PE -1.75

PB -21.49

EV/EBITDA -0.69

Valuation (NTM)

Forward PE N/A

Forward PEG 0.09

Price Target $2

Cash Flow

FCF Yield -73.9%

SBC Adj. FCF Yield -81.7%

SBC Impact -10.6%

Margins

Gross Margin -360.9%

Operating Margin -914.6%

FCF Margin -1142.5%

Growth (CAGR)

Revenue 3Y | 5Y -48.6% | -8.3%

Dil EPS 3Y | 5Y 25.8% | -22.5%

FCF 3Y | 5Y 15.0% | -202.4%

Returns

ROA -58.1%

ROE -531.0%

ROIC -67.6%

Financial Health

Net Cash

$162.95M

Current Ratio 5.26

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally ...

Sector Healthcare

Industry Biotechnology

Employees 103

IPO Date Feb 6, 2019

Website www.alector.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 5, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+3.63%

Buy (3)

Hold (2)

Sell (0)

Analyst Details ➞